Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2007
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/18/2007WO2007117591A2 Total synthesis of salinosporamide a and analogs thereof
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007116101A1 Imidazo compounds
10/18/2007WO2007116100A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007WO2007116099A1 Imidazo compounds
10/18/2007WO2007116097A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
10/18/2007WO2007093870A3 A process for the preparation of risperidone
10/18/2007US20070244146 Thienopyridines as IKK inhibitors
10/18/2007US20070244104 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases
10/18/2007US20070244096 Fused Bicyclic Nitrogen-Containing Heterocycles
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007CA2649217A1 Imidazo compounds
10/18/2007CA2649214A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007CA2649213A1 Imidazo compounds
10/18/2007CA2648317A1 Total synthesis of salinosporamide a and analogs thereof
10/18/2007CA2647208A1 Glucokinase activators
10/17/2007EP1844053A2 Anti-inflammatory macrolide conjugates
10/17/2007EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
10/17/2007EP1648564B1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007CN101056880A 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc
10/17/2007CN100343668C Novel fluorescent label compounds
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/16/2007US7282505 Dissolving amorphous rapamycin in t-butyl methyl ether and recrystallizing rapamycin to form rapamycin form II; anticarcinogenic, antitumor, immunosuppressant, antiproliferative, antigunal agent
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282493 Analogs of benzoquinone-containing ansamycins and methods of use thereof
10/16/2007CA2134844C New extractive process for the recovery of naturally occurring macrolides
10/11/2007US20070238854 Heterocyclic Fused Isothiazole and Isoselenazole Monomers and Conducting Polymers
10/11/2007US20070238747 Rifamycin analogs and uses thereof
10/11/2007US20070238746 Thiazolyl-dihydro-chinazoline
10/11/2007US20070238730 Phosphatidylinositol-3-kinases inhibitors; antitumor, antiinflammatory agents; autoimmune diseases, allagies, respiratory disorders
10/11/2007US20070238723 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/11/2007US20070238721 Highly Selective Novel Amidation Method
10/11/2007US20070238718 Thiazolyl-dihydro-indazole
10/10/2007EP1841771A2 Diazabenzoýde¨anthracen-3-one compounds and methods for inhibiting parp
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/09/2007US7279580 For prophylaxis and therapy of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279571 Ascomycin is reacted with a conversion reagent that converts ascomycin to its activated derivative at C-32; activated ascomycin is then reacted with chloride ion, recovering pimecrolimus
10/04/2007WO2007110636A1 Buprenorphine derivatives and uses thereof
10/04/2007WO2007110216A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007WO2007092839A3 Macrocycle derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007060525A3 Process for preparing bicyclic pyrazolyl and imidazolyl compounds
10/04/2007WO2007053684A3 Neuroprotective agents
10/04/2007US20070232805 Modified carbocyanine dyes and their conjugates
10/04/2007US20070232604 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors
10/04/2007US20070232599 Muscarinic Acetylcholine Receptor Antagonists
10/04/2007DE102006015456A1 Bicyclische Enamino(thio)carbonylverbindungen Bicyclic enamino (thio) carbonyl compounds
10/04/2007DE102006014688A1 Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-3-one derivatives as inhibitors of lipases, and phospholipases
10/04/2007DE102005044813A1 Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln Substituted spiro-compounds and their use for preparing medicaments
10/04/2007CA2647425A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
10/04/2007CA2647417A1 Buprenorphine derivatives and uses thereof
10/03/2007EP1840123A1 Isoxazolines and their use as inhibitors of phosphodiesterase type-IV
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838715A2 Method for the preparation of maytansinoid esters
10/03/2007EP1838316A2 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
10/03/2007EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
10/03/2007CN101048416A Organic compounds
10/03/2007CN101048415A Process for the purification of tacrolimus
10/03/2007CN101048414A Fused tricyclic derivatives for the treatment of psychotic disorders
10/03/2007CN101048412A Piperidinylamino-thieno[2,3-D] pyrimidine compounds
10/03/2007CN101048386A 嘧啶衍生物 Pyrimidine derivatives
10/03/2007CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/02/2007US7276498 E.g., 9,27-dihydroxy-3-{2-[4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-37-phenyl 4,9,10,12,13,14,15,18,21,22,23,24,25,26,27,32,33,34,34a-nonadecahydro-3H-23,27-epoxy-18,15-(epoxyimino)pyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone
10/02/2007US7276497 Cytotoxic agents comprising new maytansinoids
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
09/2007
09/27/2007WO2007109080A2 Deuterated hepatitis c protease inhibitors
09/27/2007WO2007107005A1 Inhibitors of protein tyrosine kinase activity
09/27/2007US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
09/27/2007US20070225320 Process for preparing clopidogrel
09/27/2007US20070225309 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
09/27/2007US20070225292 Therapeutic Compounds: Pyridine as Scaffold
09/27/2007CA2646229A1 Deuterated hepatitis c protease inhibitors
09/26/2007EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/26/2007EP1313481B1 Pharmaceutical composition comprising condensed indole compound
09/25/2007US7273876 Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of use
09/25/2007US7273874 Formed by reacting rapamycin or an analog with an optionally substituted olefin to fuse the C26NO2 ring with a vinylene group to form a fused cyclohexene ring, which may then be hydrogenated to a cyclohexane ring; neuroprotective agents
09/25/2007US7273859 Spiro-alkane, -tetrahydrofuranfuran, -tetrahydropyran, -pyrrolidine or -piperidine fused ring pyrimidinonecarboxamides, e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-4'-oxo-spiro[cyclopentane-21,9'(6'H)-[4H]pyrido[1,2- alpha ]pyrimidine]-2'-carboxamide
09/25/2007CA2547947C Azole derivatives as active superoxide radical inhibitors
09/25/2007CA2403026C Process for the preparation of 6-o-propargyl erythromycin derivatives
09/20/2007WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives
09/20/2007US20070219233 Substituted Indoles and Their Use as Integrin Antagonists
09/20/2007US20070219188 Oxadiazine Derivatives
09/20/2007DE10216719B4 N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose N- (3-Rifamycinyl) carbamates, process for their preparation and their use in the treatment and prevention of tuberculosis
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007CA2646235A1 Non-peptidic renin inhibitors nitroderivatives
09/20/2007CA2645376A1 Aminoquinolones as gsk-3 inhibitors
09/20/2007CA2640161A1 Process for purifying tacrolimus
09/19/2007EP1833835A1 Amorphous tacrolimus and preparation thereof
09/19/2007EP1833831A1 Substituted heterocyclic compounds and methods of use
09/19/2007EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine
09/19/2007CN101039948A Rapamycin polymorphs and uses thereof
09/19/2007CN101039947A Inhibitors of hcv replication
09/19/2007CN100338073C Substituted phenylacetic acids
09/19/2007CN100338071C New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle
09/19/2007CN100338043C Method for extracting a macrolide from biomatter
09/19/2007CN100338040C Xanthine oxidase inhibitors
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 220